Diagnosing cystic fibrosis-related diabetes: current methods and challenges

References

• Cystic Fibrosis Foundation Patient registry Annual Data Report -2012. Bethesda (MD): Cystic Fibrosis Foundation; 2013.
   Google Scholar
• Shwachman H, Leubner H, Catzel P. Mucoviscidosis. Adv Pediatr. 1955;7:249–323.
   PubMedGoogle Scholar
• Moran A, Hardin D, Rodman D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract. 1999;45(1):61–73.
   PubMedGoogle Scholar
• Newsholme P, Cruzat V, Arfuso F, et al. Nutrient regulation of insulin secretion and action. J Endocrinol. 2014;221(3):R105–R120.
   PubMed Web of Science ®Google Scholar
• Meier JJ. Insulin Secretion. In: Jameson JL, De Groot LJ, editors. Endocrinology. Chapter 32. Philadelphia (PA): Elsevier; 2006.
   Google Scholar
• Daniel S, Noda M, Straub SG, et al. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes. 1999;48(9):1686–1690.
   PubMed Web of Science ®Google Scholar
• Gold G, Gishizky ML, Grodsky GM. Evidence that glucose “marks” beta cells resulting in preferential release of newly synthesized insulin. Science. 1982;218(4567):56–58.
   PubMed Web of Science ®Google Scholar
• Hellman B, Sehlin J, Taljedal IB. Calcium and secretion: distinction between two pools of glucose-sensitive calcium in pancreatic islets. Science. 1976;194(4272):1421–1423.
   PubMed Web of Science ®Google Scholar
• Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros. 2013;12(4):318–331.
   PubMed Web of Science ®Google Scholar
• Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab. 2004;287(3):E371–E385.
   PubMed Web of Science ®Google Scholar
• Iannucci A, Mukai K, Johnson D, et al. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984;15(3):278–284.
   PubMed Web of Science ®Google Scholar
• Couce M, O’Brien TD, Moran A, et al. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab. 1996;81(3):1267–1272.
   PubMed Web of Science ®Google Scholar
• Lohr M, Goertchen P, Nizze H, et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):179–185.
   PubMedGoogle Scholar
• Abdul-Karim FW, Dahms BB, Velasco ME, et al. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med. 1986;110(7):602–606.
   PubMed Web of Science ®Google Scholar
• Moran A, Pillay K, Becker DJ, et al. ISPAD clinical practice consensus guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2014;15(Suppl 20):65–76.
   PubMed Web of Science ®Google Scholar
• Ooi CY, Castellani C, Keenan K, et al. Inconclusive diagnosis of cystic fibrosis after newborn screening. Pediatrics. 2015;135(6):e1377–e1385.
   PubMed Web of Science ®Google Scholar
• Soave D, Miller MR, Keenan K, et al. Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study. Diabetes. 2014;63(6):2114–2119.
   PubMed Web of Science ®Google Scholar
• Milner AD. Blood glucose and serum insulin levels in children with cystic fibrosis. Arch Dis Child. 1969;44(235):351–355.
   PubMed Web of Science ®Google Scholar
• Olivier AK, Yi Y, Sun X, et al. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest. 2012;122(10):3755–3768.
   PubMed Web of Science ®Google Scholar
• Uc A, Olivier AK, Griffin MA, et al. Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass. Clin Sci (Lond). 2015;128(2):131–142.
   PubMed Web of Science ®Google Scholar
• Tsabari R, Elyashar HI, Cohen Cymberknown M, et al. CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation. J Cyst Fibros. 2015;15(3):e25-e27.
   PubMedGoogle Scholar
• Bellin MD, Laguna T, Leschyshyn J, et al. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study. Pediatr Diabetes. 2013;14(6):417–421.
   PubMed Web of Science ®Google Scholar
• Atlas AB, Finegold DN, Becker D, et al. Diabetic ketoacidosis in cystic fibrosis. Am J Dis Child. 1992;146(12):1457–1458.
   PubMedGoogle Scholar
• Lanng S, Thorsteinsson B, Røder ME, et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh). 1993;128(3):207–214.
   PubMedGoogle Scholar
• Hameed S, Morton JR, Jaffé A, et al. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care. 2010;33(2):221–226.
   PubMed Web of Science ®Google Scholar
• Lombardo F, De Luca F, Rosano M, et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol. 2003;149(1):53–59.
   PubMed Web of Science ®Google Scholar
• Street ME, Spaggiari C, Ziveri MA, et al. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. J Endocrinol Invest. 2012;35(3):246–253.
   PubMed Web of Science ®Google Scholar
• Ntimbane T, Comte B, Mailhot G, et al. Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev. 2009;30(4):153–177.
   PubMedGoogle Scholar
• Galli F, Battistoni A, Gambari R, et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim Biophys Acta. 2012;1822(5):690–713.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–668.
   PubMed Web of Science ®Google Scholar
• Ziai S, Coriati A, Gauthier M-S, et al. Could T cells be involved in lung deterioration and hyperglycemia in cystic fibrosis? Diabetes Res Clin Pract. 2014;105(1):22–29.
   PubMed Web of Science ®Google Scholar
• Barrio R. Management of endocrine disease: cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues. Eur J Endocrinol. 2015;172(4):R131–R141.
   Google Scholar
• Mohan K, Miller H, Dyce P, et al. Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med. 2009;26(6):582–588.
   PubMed Web of Science ®Google Scholar
• Moran A, Pyzdrowski KL, Weinreb J, et al. Insulin sensitivity in cystic fibrosis. Diabetes. 1994;43(8):1020–1026.
   PubMed Web of Science ®Google Scholar
• Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 1994;43(2):163–167.
   PubMed Web of Science ®Google Scholar
• Hardin DS, Leblanc A, Marshall G, et al. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab. 2001;281(5):E1022–E1028.
   PubMed Web of Science ®Google Scholar
• Amiel SA, Sherwin RS, Simonson DC, et al. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315(4):215–219.
   PubMed Web of Science ®Google Scholar
• Hardin DS, Rice J, Cohen RC, et al. The metabolic effects of pregnancy in cystic fibrosis. Obstet Gynecol. 2005;106(2):367–375.
   PubMed Web of Science ®Google Scholar
• Marshall BC, Butler SM, Stoddard M, et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr. 2005;146(5):681–687.
   PubMed Web of Science ®Google Scholar
• Gelfand IM, Eugster EA, Haddad NG. Infancy-onset cystic fibrosis-related diabetes. Diabetes Care. 2005;28(10):2593–2594.
   PubMed Web of Science ®Google Scholar
• Rosenecker J, Eichler I, Kühn L, et al. Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter cystic fibrosis study group. J Pediatr. 1995;127(3):441–443.
   PubMed Web of Science ®Google Scholar
• Lanng S, Thorsteinsson B, Lund-Andersen C, et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994;83(1):72–77.
   PubMed Web of Science ®Google Scholar
• Moran A, Doherty L, Wang X, et al. Abnormal glucose metabolism in cystic fibrosis. J Pediatr. 1998;133(1):10–17.
   PubMed Web of Science ®Google Scholar
• Dupuis A, Keenan K, Ooi CY, et al. Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Genet Med. 2015;18(4):333–340.
   PubMed Web of Science ®Google Scholar
• Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140(1):153–161.
   PubMed Web of Science ®Google Scholar
• Boyle MP, De Boeck K. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. Lancet Respir Med. 2013;1(2):158–163.
   PubMed Web of Science ®Google Scholar
• Adler AI, Shine BSF, Chamnan P, et al. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care. 2008;31(9):1789–1794.
   PubMed Web of Science ®Google Scholar
• Rowland M, Gallagher CG, O’Laoide R, et al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol. 2011;106(1):104–109.
   PubMed Web of Science ®Google Scholar
• Leung DH, Ye W, Molleston JP, et al. Baseline ultrasound and clinical correlates in children with cystic fibrosis. J Pediatr. 2015;167(4):862–868. e2
   PubMed Web of Science ®Google Scholar
• Hardin DS, Ahn C, Rice J, et al. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes. J Investig Med. 2008;56(3):567–573.
   PubMed Web of Science ®Google Scholar
• Blackman SM, Hsu S, Ritter SE, et al. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia. 2009;52(9):1858–1865.
   PubMed Web of Science ®Google Scholar
• Blackman SM, Hsu S, Vanscoy LL, et al. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab. 2009;94(4):1302–1309.
   PubMed Web of Science ®Google Scholar
• Schmid K, Fink K, Holl RW, et al. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros. 2014;13(1):80–85.
   PubMed Web of Science ®Google Scholar
• McKenzie MD, Jamieson E, Jansen ES, et al. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes. 2010;59(3):644–652.
   PubMed Web of Science ®Google Scholar
• van den Borst B, Gosker HR, Zeegers MP, et al. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.
   PubMed Web of Science ®Google Scholar
• Lanng S, Hansen A, Thorsteinsson B, et al. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995;311(7006):655–659.
   PubMed Web of Science ®Google Scholar
• Ode KL, Frohnert B, Laguna T, et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes. 2010;11(7):487–492.
   PubMed Web of Science ®Google Scholar
• Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med. 2004;21(7):691–696.
   PubMed Web of Science ®Google Scholar
• O’Riordan SM, Hindmarsh P, Hill NR, et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care. 2009;32(6):1020–1022.
   PubMedGoogle Scholar
• Koch C, Rainisio M, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol. 2001;32(5):343–350.
   PubMed Web of Science ®Google Scholar
• Finkelstein SM, Wielinski CL, Elliott GR, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988;112(3):373–377.
   PubMed Web of Science ®Google Scholar
• Lanng S, Thorsteinsson B, Nerup J, et al. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994;83(8):849–853.
   PubMed Web of Science ®Google Scholar
• Lanng S, Thorsteinsson B, Nerup J, et al. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992;151(9):684–687.
   PubMed Web of Science ®Google Scholar
• Waugh N, Royle P, Snaith A, et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol Assess. 2012;16(24):1–179.
   PubMed Web of Science ®Google Scholar
• Brennan AL, Gyi KM, Wood DM, et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros. 2007;6(2):101–109.
   PubMed Web of Science ®Google Scholar
• Hunt WR, Zughaier SM, Guentert DE, et al. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes. Am J Physiol Lung Cell Mol Physiol. 2014;306(1):L43–L49.
   PubMed Web of Science ®Google Scholar
• Clarke LL, Grubb BR, Yankaskas JR, et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr (-/-) mice. Proc Natl Acad Sci. 1994;91(2):479–483.
   PubMed Web of Science ®Google Scholar
• Gray MA, Winpenny JP, Porteous DJ, et al. CFTR and calcium-activated chloride currents in pancreatic duct cells of a transgenic CF mouse. Am J Physiology-Cell Physiol. 1994;266(1):C213–C221.
   Google Scholar
• Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science. 1992;257(5073):1083–1088.
   PubMed Web of Science ®Google Scholar
• Pascua P, García M, Fernández-Salazar MP, et al. Ducts isolated from the pancreas of CFTR-null mice secrete fluid. Pflügers Archiv-European J Physiol. 2009;459(1):203–214.
   PubMed Web of Science ®Google Scholar
• Wood DM, Brennan AL, Philips BJ, et al. Effect of hyperglycaemia on glucose concentration of human nasal secretions. Clin Sci (Lond). 2004;106(5):527–533.
   PubMed Web of Science ®Google Scholar
• Philips BJ, Redman J, Brennan A, et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005;60(9):761–764.
   PubMed Web of Science ®Google Scholar
• Noronha RM, Damaceno N, Muramatu LH, et al. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus. Pediatr Diabetes. 2014;15(4):309–312.
   PubMed Web of Science ®Google Scholar
• Rana M, Munns CF, Selvadurai HC, et al. Increased detection of cystic-fibrosis-related diabetes in Australia. Arch Dis Child. 2011;96(9):823–826.
   PubMed Web of Science ®Google Scholar
• Moran A, Brunzell C, Cohen RC, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33(12):2697–2708.
   PubMed Web of Science ®Google Scholar
• Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32(9):1626–1631.
   PubMed Web of Science ®Google Scholar
• Lewis C, Blackman SM, Nelson A, et al. Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. Am J Respir Crit Care Med. 2015;191(2):194–200.
   PubMed Web of Science ®Google Scholar
• Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet. 1971;2(7716):125–128.
   PubMed Web of Science ®Google Scholar
• Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162(3 Pt 1):891–895.
   PubMed Web of Science ®Google Scholar
• Widger J, Oliver MR, O’Connell M, et al. Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis. PLoS One. 2012;7(9):e44844.
   Google Scholar
• Hameed S, Jaffe A, Verge CF. Cystic fibrosis related diabetes (CFRD)–the end stage of progressive insulin deficiency. Pediatr Pulmonol. 2011;46(8):747–760.
   PubMed Web of Science ®Google Scholar
• Moran A, Pekow P, Grover P, et al. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care. 2009;32(10):1783–1788.
   PubMed Web of Science ®Google Scholar
• Widger J, Ranganathan S, Robinson PJ. Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes. J Cyst Fibros. 2013;12(3):216–221.
   PubMed Web of Science ®Google Scholar
• Brodsky J, Dougherty S, Makani R, et al. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care. 2011;34(2):292–295.
   PubMed Web of Science ®Google Scholar
• Coriati A, Ziai S, Azar M, et al. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET). J Cyst Fibros. 2016;15(1):127–132.
   PubMed Web of Science ®Google Scholar
• Palerm CC. Physiologic insulin delivery with insulin feedback: a control systems perspective. Comput Methods Programs Biomed. 2011;102(2):130–137.
   PubMed Web of Science ®Google Scholar
• Hameed S, Jaffe A, Verge CF. Advances in the detection and management of cystic fibrosis related diabetes. Curr Opin Pediatr. 2015;27(4):525–533.
   PubMed Web of Science ®Google Scholar
• Scheuing N, Holl RW, Dockter G, et al. Diabetes in cystic fibrosis: multicenter screening results based on current guidelines. PLoS One. 2013;8(12):e81545.
   Google Scholar
• Frohnert BI, Ode KL, Moran A, et al. Impaired fasting glucose in cystic fibrosis. Diabetes Care. 2010;33(12):2660–2664.
   PubMed Web of Science ®Google Scholar
• Holl RW, Buck C, Babka C, et al. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care. 2000;23(1):126.
   PubMed Web of Science ®Google Scholar
• Widger J, Hameed S, Ooi CY, et al. Using HbA1c as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros. 2015;15(2):263–264.
   PubMed Web of Science ®Google Scholar
• Burgess JC, Bridges N, Banya W. HbA1c as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros. 2015;15(2):251–257.
   Web of Science ®Google Scholar
• Schnyder MA, Benden C, Schmid C. HbA1c: an effective screening tool for cystic fibrosis related diabetes? J Cyst Fibros. 2015;15(2):261–262.
   PubMed Web of Science ®Google Scholar
• Brennan AL, Gyi KM, Wood DM, et al. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros. 2006;5(1):27–31.
   PubMed Web of Science ®Google Scholar
• Godbout A, Hammana I, Potvin S, et al. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab. 2008;34(6 Pt 1):568–573.
   PubMed Web of Science ®Google Scholar
• Tofe S, Moreno JC, Máiz L, et al. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol. 2005;152(2):241–247.
   PubMed Web of Science ®Google Scholar
• Cucinotta D, De Luca F, Arrigo T, et al. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol. 1994;7(1):13–17.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–320.
   PubMed Web of Science ®Google Scholar
• Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care. 2003;26(6):1940–1941.
   PubMed Web of Science ®Google Scholar
• Moreau F, Weiller MA, Rosner V, et al. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res. 2008;40(7):502–506.
   PubMed Web of Science ®Google Scholar
• Schiaffini R, Brufani C, Russo B, et al. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol. 2010;162(4):705–710.
   PubMed Web of Science ®Google Scholar
• Leclercq A, Gauthier B, Rosner V, et al. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients. J Cyst Fibros. 2014;13(4):478–484.
   PubMed Web of Science ®Google Scholar
• Kraemer R, Rüdeberg A, Hadorn B, et al. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978;67(1):33–37.
   PubMed Web of Science ®Google Scholar
• Balzer BWR, Graham CL, Craig ME, et al. Low glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications. Nutrients. 2012;4(4):286–296.
   PubMed Web of Science ®Google Scholar
• Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med. 1989;320(9):550–554.
   PubMed Web of Science ®Google Scholar
• Gribble FM, Reimann F. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J Diabetes Complications. 2003;17(2 Suppl):11–15.
   PubMed Web of Science ®Google Scholar
• Moran A, Becker D, Casella SJ, et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care. 2010;33(12):2677–2683.
   PubMed Web of Science ®Google Scholar
• Sc NN, Shoseyov D, Kerem E, et al. Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation. J Cyst Fibros. 2010;9(3):199–204.
   PubMed Web of Science ®Google Scholar
• Mohan K, Israel KL, Miller H, et al. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration. 2008;76(2):181–186.
   PubMed Web of Science ®Google Scholar
• Hameed S, Morton JR, Field PI, et al. Once daily insulin detemir in cystic fibrosis with insulin deficiency. Arch Dis Child. 2012;97(5):464–467.
   PubMed Web of Science ®Google Scholar
• Hardin DS, Rice J, Rice M, et al. Use of the insulin pump in treat cystic fibrosis related diabetes. J Cyst Fibros. 2009;8(3):174–178.
   PubMed Web of Science ®Google Scholar
• Scheuing N, Badenhoop K, Borkenstein M, et al. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes? Pediatr Diabetes. 2015;16(1):10–15.
   PubMed Web of Science ®Google Scholar
• Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med. 2015;373(22):2129–2140.
   PubMed Web of Science ®Google Scholar
• Dobson L, Hattersley AT, Tiley S, et al. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002;87(5):430–431.
   PubMed Web of Science ®Google Scholar
• Mozzillo E, Franzese A, Valerio G, et al. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatr Diabetes. 2009;10(3):162–167.
   PubMed Web of Science ®Google Scholar
• Bizzarri C, Lucidi V, Ciampalini P, et al. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest. 2006;29(3):RC1–R14.
   PubMed Web of Science ®Google Scholar
• Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298(2):194–206.
   PubMed Web of Science ®Google Scholar
• Anzeneder L, Kircher F, Feghelm N, et al. Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis. Horm Metab Res. 2011;43(5):355–360.
   PubMed Web of Science ®Google Scholar
• O’Donovan D, Horowitz M, Russo A, et al. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes. Diabetologia. 2004;47(12):2208–2214.
   PubMed Web of Science ®Google Scholar
• Perano S, Rayner CK, Couper J, et al. Cystic fibrosis related diabetes–a new perspective on the optimal management of postprandial glycemia. J Diabetes Complications. 2014;28(6):904–911.
   PubMed Web of Science ®Google Scholar